Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium

Pharvaris N.V. - Ordinary Shares (PHVS) 
Company Research Source: GlobeNewswire
ZUG, Switzerland, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat hereditary angioedema (HAE) attacks, today announced the acceptance of two abstracts for oral presentation and ten abstracts for poster presentation at the upcoming 7th Bradykinin Symposium, to be held from September 5-6, 2024, in Berlin, Germany. Presentation details are as follows: Title: Bradykinin Challenge Model in Humanized Bradykinin B2 receptor Transgenic RatPresenter: Jolanta Skarbaliene, Ph.D.Format: Oral Presentation, Session IIDate, time: Thursday, Sept. 5, 15.05-15.15 CEST (9:05-9:15 a.m. EDT) Title: Prophylactic Treatment with Deucrictibant Improves HAE Disease Control and HRQoLPresenter: Markus Magerl, M.D.Format: Oral Presentation, Session VIIDate, time: Friday, Sept. 6, 15.05-15.15 CEST (9:05-9:15 a.m. EDT) Title: Long-Term Safety and Efficacy of Show less Read more
Impact Snapshot
Event Time:
PHVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PHVS alerts
Opt-in for
PHVS alerts

from News Quantified
Opt-in for
PHVS alerts

from News Quantified